MENU
LED Medical Diagnostics Inc. (“LED” or the “Company”) (TSX-V: LMD) is pleased to announce the results of a meta-analysis on the clinical use of autofluorescence to assess its accuracy for oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders…
We use cookies to make your website experience better. By accepting this notice and continuing to browse our website you confirm you accept our Terms of Use & Privacy Policy.
read more >>